Argatra 100mg/ml, Konzentrat zur Herstellung einer Infusionslösung

7680628610015 CH-62861 Konzentrat
Argatra 100mg/ml, Konzentrat zur Herstellung einer Infusionslösung
Argatra 100mg/ml, Konzentrat zur Herstellung einer Infusionslösung
Argatra 100mg/ml, Konzentrat zur Herstellung einer Infusionslösung
1 / 3
google

Article details

Package size
1 x 2.5 ml
Selling units
1
Measure
Durchstechflasche(n)
Galenic form
Konzentrat
Galenic group
Tinkturen/Desinfektion

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
10/03/2025
Summary of Product Characteristics
Français
10/03/2025
Summary of Product Characteristics
Italien
10/03/2025

Detailed composition

Substance Quantity Type Category
(N/A)
100.0 MG Substance Wirkstoff (Principe actif)
(N/A)
96.5 MG Substance WIIS
(N/A)
300.0 MG Substance HBESI
(N/A)
400.0 MG Substance HBESI
(N/A)
- Substance HNIDK

Authorization holder

Medius AG

4132 Muttenz

Authorization information

Swissmedic authorization number
62861
Drug name
Argatra, Konzentrat zur Herstellung einer Infusionslösung
Galenic form
KOINF
ATC Code
B01AE03
Authorization status
Z
Dispensing category
B
First authorization
30/12/2014
Authorization expiration date
31/12/9999
IT Number
06.03.0.
Domain
Human medicine
Field of application
Antikoagulation bei erwachsenen Patienten mit HIT-II

Package details

Description (FR)
ARGATRA conc perf 250 mg/2.5ml flac 2.5 ml
Description (DE)
ARGATRA Inf Konz 250 mg/2.5ml Durchstf 2.5 ml
Market launch
30/12/2014
Narcotic (BTM)
No

Other package sizes (1)

None
6 x 2.5 ml DUR
GTIN: None
Not in V1